Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from miR-4759 suppresses breast cancer through immune checkpoint blockade. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3322/caac.21492
10.3322/caac.21492 · External reference
10.1038/nm.3944
10.1038/nm.3944 · External reference
10.1038/nrc3239
10.1038/nrc3239 · External reference
10.1038/s41422-020-0343-4
10.1038/s41422-020-0343-4 · External reference
10.1038/nri.2017.112
10.1038/nri.2017.112 · External reference
10.1126/science.aar4060
10.1126/science.aar4060 · External reference
Unresolved reference
2016 · External reference
10.1016/j.tcb.2019.07.002
10.1016/j.tcb.2019.07.002 · External reference
STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
2018 · External reference
10.1016/j.ccell.2018.01.009
10.1016/j.ccell.2018.01.009 · External reference
10.1016/j.celrep.2017.07.027
10.1016/j.celrep.2017.07.027 · External reference
10.1038/s41586-018-0756-0
10.1038/s41586-018-0756-0 · External reference
Potential regulatory roles of microRNAs and long noncoding RNAs in anticancer therapies
10.1016/j.omtn.2018.08.019 · 2018 · External reference
miRNAs, cancer, and stem cell division
10.1016/j.cell.2005.06.036 · 2005 · External reference
MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer
10.1016/j.immuni.2012.12.006 · 2013 · External reference
10.1016/j.cellimm.2017.01.005
10.1016/j.cellimm.2017.01.005 · External reference
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
10.1093/neuonc/nov292 · 2016 · External reference
MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR
10.1002/ijc.30912 · 2017 · External reference
DriverDBv3: a multi-omics database for cancer driver gene research
2019 · External reference
10.1093/nar/gkv1314
10.1093/nar/gkv1314 · External reference
10.1093/nar/gkt1025
10.1093/nar/gkt1025 · External reference
YM500v3: a database for small RNA sequencing in human cancer research
10.1093/nar/gkw1084 · 2017 · External reference
YM500v2: a small RNA sequencing (smRNA-seq) database for human cancer miRNome research
10.1093/nar/gku1156 · 2015 · External reference
10.1093/nar/gks1238
10.1093/nar/gks1238 · External reference
miRTarBase 2020: updates to the experimentally validated microRNA–target interaction database
10.1093/nar/gkz896 · 2019 · External reference
10.1186/gb-2010-11-10-r106
10.1186/gb-2010-11-10-r106 · External reference
10.1186/1746-4811-3-12
10.1186/1746-4811-3-12 · External reference
10.1371/journal.pone.0055168
10.1371/journal.pone.0055168 · External reference
10.4049/jimmunol.172.5.2778
10.4049/jimmunol.172.5.2778 · External reference
10.1371/journal.pone.0006600
10.1371/journal.pone.0006600 · External reference
10.1111/cas.14069
10.1111/cas.14069 · External reference
HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families
10.1080/2162402x.2015.1026534 · 2015 · External reference
Beyond CTLA-4 and PD-1, the generation Z of negative checkpoint regulators
10.3389/fimmu.2015.00418 · 2015 · External reference
10.1038/ni1443
10.1038/ni1443 · External reference
10.4049/jimmunol.173.4.2500
10.4049/jimmunol.173.4.2500 · External reference
Potential targeting of B7–H4 for the treatment of cancer
10.1111/imr.12530 · 2017 · External reference
Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis
10.1186/1479-5876-5-27 · 2007 · External reference
10.1084/jem.20150785
10.1084/jem.20150785 · External reference
Co-inhibition of TIGIT, PD1, and Tim3 reverses dysfunction of Wilms tumor protein-1 (WT1)-specific CD8+ T lymphocytes after dendritic cell vaccination in gastric cancer
2018 · External reference
CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma
2020 · External reference
10.1084/jem.20100643
10.1084/jem.20100643 · External reference
10.1038/ni944
10.1038/ni944 · External reference
10.1038/leu.2011.1
10.1038/leu.2011.1 · External reference
Expression of CD200 on AML blasts directly suppresses memory T-cell function
10.1038/leu.2012.77 · 2012 · External reference
10.1007/s00262-014-1549-4
10.1007/s00262-014-1549-4 · External reference
10.1016/1074-7613(94)90071-x
10.1016/1074-7613(94)90071-x · External reference
Antibody and fragment-based PET imaging of CTLA-4+ T-cells in humanized mouse models
2019 · External reference
10.1002/eji.1830250949
10.1002/eji.1830250949 · External reference
10.1111/j.1749-6632.2010.05919.x
10.1111/j.1749-6632.2010.05919.x · External reference
The emerging role of CD244 signaling in immune cells of the tumor microenvironment
10.3389/fimmu.2018.02809 · 2018 · External reference
CD160 and BTLA: LIGHTs out for CD4+ T cells
10.1038/ni0208-122 · 2008 · External reference
10.1038/s41577-019-0224-6
10.1038/s41577-019-0224-6 · External reference
10.1158/2326-6066.cir-18-0637
10.1158/2326-6066.cir-18-0637 · External reference
10.1016/j.it.2016.10.002
10.1016/j.it.2016.10.002 · External reference
10.1158/0008-5472.can-13-3581
10.1158/0008-5472.can-13-3581 · External reference
10.1016/j.cyto.2015.11.011
10.1016/j.cyto.2015.11.011 · External reference
CCL7 Signaling in the Tumor Microenvironment
10.1007/978-3-030-36667-4_4 · 2020 · External reference
10.1186/s12943-020-01234-1
10.1186/s12943-020-01234-1 · External reference
10.1080/2162402x.2015.1075114
10.1080/2162402x.2015.1075114 · External reference
10.1111/febs.14030
10.1111/febs.14030 · External reference
10.1093/jnci/djv303
10.1093/jnci/djv303 · External reference
10.1038/ncomms6241
10.1038/ncomms6241 · External reference
10.1056/nejmoa1809615
10.1056/nejmoa1809615 · 2018 · External reference
10.1172/jci80011
10.1172/jci80011 · External reference
Novel targeted therapies for metastatic breast cancer
10.21037/atm.2020.03.43 · 2020 · External reference
10.1172/jci126022
10.1172/jci126022 · External reference
10.1158/0008-5472.can-18-1892
10.1158/0008-5472.can-18-1892 · External reference
10.1038/ncomms12632
10.1038/ncomms12632 · External reference
10.1016/j.molcel.2019.04.005
10.1016/j.molcel.2019.04.005 · External reference
